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The history of medicine serves several useful functions
today, when doctors and the American health care system
confront many challenges. Physicians live and work in an
era of escalating expectations, eroding autonomy, and de-
creasing discretionary time. There is so much—far too
much—to know, to learn, and to do. Understandably, many
doctors are concerned about the future of medicine as they
watch so many powerful political, economic, and social
forces transform medical practice, research, and education.
In this context, the history of medicine provides useful
perspective and teaches valuable lessons. Just as a patient’s
history helps us assess the significance of their symptoms
and develop a diagnostic and therapeutic strategy, the
history of medicine provides important perspective on
present and future challenges and opportunities.
Medical history research and publishing have grown
dramatically in recent years. The field has been energized by
an infusion of trained professionals who have brought with
them a variety of interesting and innovative approaches.
Some have medical training, but many do not. In addition
to a growing number of physician-historians, there are social
historians, sociologists, economists, and members of a dozen
different disciplines who share an interest in the history of
health care. Meanwhile, more historical studies focus on the
recent rather than the remote past. As a result, the history of
medicine has become more accessible and more relevant.
This new type of history seeks to blend the scientific and
social dimensions of medicine. This makes sense if you
consider the profound effects that external forces have on
present-day medicine. Think, for example, of the incredible
impact Medicare reimbursement has on cardiology and of
the crucial (and understandably self-interested) role the phar-
maceutical industry plays in funding clinical trials. By under-
standing how current circumstances such as these evolved, we
can better anticipate, evaluate, and potentially influence the
various factors that will shape the future of health care.
Many prominent physicians have promoted medical his-
tory as a tool to better understand diseases and to help frame
the present and speculate on the future. William Osler (1),
the English-speaking world’s leading physician a century
ago, put it this way: “By the historical method alone can
many problems in medicine be approached profitably.” Paul
Dudley White (2), America’s first academic cardiologist,
also thought medical history was important. By looking
back, he wrote in 1950, “we acquire a better perspective of
our own place in history with the humbling realization of
our role as merely a link in the long chain of the acquisition
and application of medical knowledge.”
MILLISECONDS OR
MILLENIA: LIFE IN THE FAST LANE
Cardiologists can benefit from historical perspective as
much as anyone, despite the fact that our specialty focuses
on tiny units of time. Electrophysiologists record events in
milliseconds. Echocardiographers measure blood flow in
seconds. Interventionalists count balloon inflation time in
minutes. In historical terms, these units of measurement are
irrelevant. That’s not to imply, however, that specific events
in unique patients are insignificant. Cardiac pathophysiol-
ogy and our patients’ problems force us to focus on short
intervals. Understandably, most of us are too busy thinking
about the events of the moment, the hour, or the day to pay
much attention to historical trends measured in years or
decades, let alone centuries. I would encourage you, how-
ever, to view contemporary challenges and opportunities in
a larger historical context.
The pace of discovery and innovation in American
cardiology has accelerated for five decades, fueled by a blend
of altruism and entrepreneurialism and supercharged by
massive federal funding, the high prevalence of cardiovas-
cular disease, and increasing societal expectations. As a
result, physicians, hospitals, insurers, and our government
now struggle with whether, when, and how to incorporate
new drugs, devices, and techniques into clinical practice.
The challenge is compounded because contemporary Amer-
ican culture covets the “newest” and “latest” of everything!
Our obsession with newness isn’t new, however. Chicago
physician James Herrick (3), best known for his classic
description of acute myocardial infarction (MI), declared in
1903, “There is a tendency in these hurrying modern times
to seize upon that which is new and quickly to forget the
old.” I’m not sure whether it’s reassuring or disconcerting
that this quotation was published a century ago. Regardless,
Herrick’s rhetoric reminds us that “hurry” and “modern” are
relative terms.
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Today, physicians are inundated with information and
requests for information. In recent years, 24/7 cable news,
cell phones, and the Internet, with its e-mail and intrusive
instant messaging, have contributed to our infatuation with
up-to-the-minute information and constant connectivity.
Long before the invention of telephones and televisions—not
to mention computers and the World Wide Web—physicians
placed a premium on timely, up-to-date knowledge. Genera-
tions ago, overwhelmed by all they had to learn, ambitious
American doctors were frustrated by the short lifespan of the
new knowledge of their day. For example, Harvard physician
Henry Ingersoll Bowditch (4) declared in 1867, “Modern
science does not let any book remain long useful.”
During the 19th century, journals rapidly replaced books
as the primary vehicle for documenting and distributing new
knowledge. In 1893, Philadelphia physician and editor
George Gould (5) declared that the medical profession
suffered from “journalopathy.” He protested, “We are, in
fact, fast becoming journalomaniacs. We are frittering away
our professional time, money, and energy in the useless
multiplication of medical journals.” But reflect on this: when
Gould wrote those provocative words, there were no cardi-
ology journals of any kind—anywhere in the world. This is
not surprising, because the specialty of cardiology is a
20th-century invention (6).
Today, there are more than 100 cardiology journals
published around the world, and—despite our current
infatuation with internet-based information transfer—
several new ones are launched each year. It’s doubtful that
this steep trajectory of journals will persist much longer.
Most medical journals depend on advertising income, but
pharmaceutical companies are pumping more and more
money into direct-to-consumer advertising each year. On
the other hand, I predict that electronic education will
complement paper-based education rather than replace it.
Several earlier pessimistic prognostications about informa-
tion and entertainment technology proved wrong: television
did not totally replace radio; videotape players did not
dramatically decrease demand for local cinema; and CD-
ROM did not decrease the market for printed textbooks.
History can also teach us about ourselves: how we, as
individual physicians, confront change and challenges.
Much has been written about physician burnout in this era
of managed care, but the phenomenon is not new. Medical
history provides a useful perspective on this perplexing
problem. In a series of letters that William Osler (7) wrote
in 1904 to friends and colleagues, he explained his decision
to leave Johns Hopkins to become Regius Professor of
Medicine at Oxford in words and phrases that reflected his
personal struggle with burnout. These letters, written when
Osler was 54 years old, contain compelling evidence: “I am
tired of the incessant racket of my present life.” “I could not
possibly last long at my present pace.” “I am tired of the
strain of the past few years which could only have one
end—a breakdown.” When I published an article on Osler’s
personal struggle with burnout in The New England Journal
of Medicine in 1989, several doctors wrote to me to express
their relief that someone as seemingly successful as Osler
had, in fact, suffered from burnout.
HISTORY, HUMILITY, AND WHAT IS TRUTH
History also teaches humility. I could cite many examples
that apply to institutions, organizations, nations, and entire
cultures, but I will focus on humility at the level of the
individual. The aphorism “fame is fleeting” applies to
medicine, as it does to any other area of human endeavor.
Almost all of the most influential physicians and medical
scientists of earlier generations are now forgotten. Even
earning an eponym or winning a Nobel Prize—or both—
does not immunize one against obscurity. For example, I
doubt that many cardiologists know who Willem Einthoven
was, where he worked, or what he accomplished, despite the
fact that 2002 is the centennial of his invention of the
electrocardiograph. I understand those who say, “Who
cares?” Compared with the “who, what, where, and when”
questions, I find the “why and so what” questions much
more interesting and informative. For example, what led
Einthoven to invent the electrocardiograph and what was
the significance of his invention in terms of research, patient
care, and the development of cardiology as a specialty (8).
The answers to those historical questions provide perspec-
tive on the present-day dynamics of discovery, dissemina-
tion of new knowledge, and discipline-building.
History is also humbling because it shows how ephemeral
“expert opinions” can be. Increasingly, therapeutic decisions
in cardiology are guided by evidence derived from random-
ized clinical trials that are customized for a unique patient.
Most of our management decisions, however, are still based
on traditions of care that have been shaped by less rigorous
data or by the opinions of experts. The missionaries of
evidence-based medicine rightly point out that history
reveals that “opinion leaders” are sometimes wrong—
occasionally very wrong. Having said this, I want to em-
phasize that it is important to guard against “presentism,” that
is, the tendency to evaluate the attitudes and actions of earlier
generations of physicians in terms of our current understanding
and approaches. Rather, we must judge their recommendations
and practices in terms of their scientific and social context
rather than our own. Future generations will surely view some
of our current theories of pathophysiology as naı¨ve and our
“state-of-the-art” treatments as primitive and misguided. A
few historical examples illustrate the point.
Two hundred years ago, many leading physicians of
Europe and North America used leeches and lancets to
bleed patients with “fever” and various other problems.
George Washington’s death in 1799 was accelerated by
aggressive blood-letting. During a 13-h period shortly
before his death, doctors removed 2.5 quarts of blood from
the former president. By current standards, this “treatment”
seems incomprehensible (if not homicidal). Then, however,
blood-letting was championed by many prominent physi-
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cians, notably Benjamin Rush, a physician-signer of the
Declaration of Independence. This “heroic” therapy re-
flected the lingering influence of Galen’s humoral pathology
(after 1,500 years) and late 18th-century interpretations of
pathophysiology.
History also provides many examples of the time lag that
often separates the announcement of an innovation and its
acceptance. The 20th-century history of the diagnosis and
treatment of coronary heart disease illustrates how some
new pathophysiological interpretations and innovations in
diagnosis and treatment that proved correct or useful were
ignored or worse. James Herrick’s comprehensive synthesis
of the pathophysiology, clinical features, and consequences
of coronary thrombosis (acute MI) is now considered a
classic contribution to cardiological knowledge.
When Herrick published his detailed review in the
Journal of the American Medical Association in 1912, it had no
significant impact on practice. More than anything, doctors
needed an objective tool to help them recognize coronary
thrombosis (Herrick’s term). He gave them just that when
he first reported the typical electrocardiographic features of
coronary thrombosis in 1919. The other lesson to be learned
from Herrick’s classic review is that he (like Osler) did not
sense any artificial boundary between where a review of the
literature ends and medical history begins (9).
It often takes time to identify and acknowledge what turn
out to be important innovations or observations. Some-
times, the early response to a medical or surgical innovation
is not simply passive disinterest, it is an active attempt to
discredit the observation or the observer. When German
surgical resident Werner Forssmann published the first
description of cardiac catheterization in a human (himself)
in 1929, Ferdinand Sauerbruch, his chief of surgery and a
leading academic of the time, ridiculed the technique and
fired him. Eventually, in 1956, Forssmann shared the Nobel
Prize for his contribution to the invention of cardiac
catheterization with Andre´ Cournand and Dickinson Rich-
ards. Cournand is another cardiological pioneer who, de-
spite an eponym and a Nobel Prize, has faded into obscurity.
Medical history provides many compelling examples of
how the impact of opinion leaders can retard as well as
accelerate medical “progress.” Their personal experience
with a specific condition may be extensive, but this does not
insulate them from false assumptions or unrecognized bias.
Writing about MI in the 1951 edition of his widely read
textbook, Paul White (10) explained, “As the result of
experience during the last twenty five years, I have found
that a very satisfactory plan of treatment for the average case
of acute MI is one month of full [bed] rest . . . [followed by]
one month of gradually increasing activity (the first week in
a chair a little more each day, the second week walking on
the level increasing distances, the third week going slowly
over the stairs once a day, and the fourth week going out for
short daily rides . . . and a third month if possible to
consolidate the recovery.”
At the same time, Britain’s leading cardiologist, Paul
Wood (11), wrote in his influential textbook, “Patients
should be confined to bed at once and should remain for
three to six weeks, or longer, according to the severity of the
illness and to the behaviour of the sedimentation rate and
the electrocardiogram.” Today, when our approach to treat-
ing acute MI could be characterized as hyperactive (and
understandably so), the recommendations of two of the
world’s most influential cardiologists a half-century ago
seem incomprehensible. These opinion leaders based their
advice on tradition, then-current pathophysiological theo-
ries, and their extensive personal experience.
Many readers will be surprised to learn that White and
Wood made their recommendations before the first ran-
domized clinical trial was published (on streptomycin ther-
apy of tuberculosis) in 1952. In recent decades, evidence-
based medicine has helped define effective therapy,
especially in cardiology. Nevertheless, and understandably,
we still read and hear strong statements from leading thinkers
whose recommendations blend various levels of evidence with
personal opinions that reflect many influences. The history of
medicine demonstrates that dogmatic statements sometimes
appear quite foolish in a few years or decades.
The history of coronary angiography provides a poignant
example of resistance to innovation. Mason Sones Jr.
published a concise description of his technique of selective
coronary angiography in 1962. This procedure made it
possible for the first time to visualize the entire coronary
arterial system in living humans. It is hard to imagine
cardiology and cardiac surgery today without this valuable
technique that catalyzed thousands of careers and a multi-
tude of industries. Although several cardiologists in aca-
demic centers and referral hospitals embraced the technique
almost immediately, a few influential voices urged caution.
Four years after Sones’s paper appeared, a writer editorial-
ized in the Lancet (12), “Sufficient time has elapsed since the
introduction of coronary arteriography for its usefulness to
be assessed. As an aid to diagnosis in ischemic heart-disease,
it seems at present to offer little that cannot be more easily
obtained by much simpler methods, such as good history-
taking and electrocardiography.”
George Burch, a prominent academic cardiologist who
was editor of the American Heart Journal and a former
president of the American College of Cardiology, harshly
criticized selective coronary angiography more than a decade
after its introduction. By then, the technique was widely
accepted as the definitive tool for defining the location and
severity of coronary obstructions. Nevertheless, Burch (13),
known for his conservatism with respect to newer diagnostic
methods, declared that coronary angiography “[is] a hazard-
ous and inadequate method for visualizing the coronary
arteries, [that] is not nearly as effective in diagnosis and
evaluation of ischemic heart disease as are a careful history,
physical examination, electrocardiogram, and cardiac fluo-
roscopy.” Once again, this rather chilling quotation dem-
onstrates the danger of dogmatic statements, especially if
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they are based mainly on personal opinion that can be biased
in many ways for a variety of reasons.
This brief essay contains just a few examples of how
medical history provides a useful perspective for evaluating
the present and speculating about the future. History
teaches many valuable lessons that can inform our decisions
and help predict the consequences of our actions. Other
essays have discussed several additional reasons that cardiolo-
gists, in particular, will find the history of medicine entertain-
ing as well as enlightening (14,15). There is a wealth of
interesting historical material out there. I urge you to explore it.
The National Library of Medicine has made it easy to get
started. Visit their Web site (www.nlm.nih.gov) and click on
MEDLINE/PubMed. There, click on “Limits” and select
“History of Medicine” under “subsets.” The next steps are
rather straightforward. By limiting the language to English and
entering aortic stenosis, for example, 27 citations are returned.
When you enter the world of medical history, you have
embarked on an interesting journey through time. I think you
will enjoy the trip and the broader perspective it provides.
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